COVID Vaccine: Zydus Cadila To Begin Phase II Clinical Trials From Aug 6
New Delhi: Phase I clinical trial of the COVID-19 vaccine candidate, ZyCoV-D of the drug firm Zydus Cadila has been completed and phase II of the clinical trials will commence from August 6.
"ZyCoV-D was found to be safe and well-tolerated…